A new study in the Journal of Pain Research, led by Geoffroy Laumet at Michigan State University, reports that blocking the immune signaling molecule TNF-α after a surgical incision can prolong pain in mice. The team used a mouse model and inhibited TNF-α by three different methods, one of which was Etanercept, an FDA-approved drug used in humans.
Contrary to expectations, animals with TNF-α activity blocked experienced pain for a much longer period. Laumet says blocking TNF-α seemed to prevent the body from turning off pain through its normal processes. The effect was consistent across repeated experiments by multiple lab members and with several inhibition techniques, which strengthens the finding.
The authors point out that about 90% of people recover from post-surgical pain while roughly 10% develop chronic postsurgical pain. More than 40 million Americans have surgery each year, and the study estimates roughly 4 million may develop long-lasting pain annually. The team suggests that the body’s ability to produce TNF-α after an incision could be a critical factor in whether pain resolves.
They caution that the results do not mean stopping all anti-inflammatory treatment. Many molecules control inflammation, pain and healing, and some situations—such as reducing joint inflammation in rheumatoid arthritis—still benefit from lowering inflammation. Laumet expresses optimism that future treatments might block pain while allowing healing inflammation to continue.
Difficult words
- TNF-α — a protein involved in immune signaling
- inhibit — to stop or reduce an actioninhibited
- prolong — to make something last for longer
- incision — a cut made during a surgery
- inflammation — the body's response that causes swelling
- chronic — continuing for a long time or persistent
- resolve — to end or be cured over timeresolves
Tip: hover, focus or tap highlighted words in the article to see quick definitions while you read or listen.
Discussion questions
- Why might blocking an immune signaling molecule prolong pain after surgery? Give reasons based on the article.
- How could the finding that TNF-α helps pain resolve affect decisions about using anti-inflammatory drugs after surgery?
- What further evidence or experiments would you want to see before changing clinical practice about post-surgical inflammation?
Related articles
Simpler treatment trial for cryptococcal meningitis in Malawi
Cryptococcal meningitis kills many people in Sub‑Saharan Africa and mainly affects people with HIV. A Phase II trial in Lilongwe is testing a sustained‑release flucytosine pellet to make treatment easier, while clinicians warn that early testing and care remain vital.
Ancestral healing in the Caribbean
Ancestral healing asks societies to face historical wounds so people can live healthier lives. In the Caribbean, educators combine shamanic practices, nervous-system work and cultural rituals with scientific findings about trauma and community care.
Teen drug use in the US stays near pandemic low
For the fifth year in a row, use of most substances among US teenagers remains close to the low point reached in 2021, according to the University of Michigan's Monitoring the Future survey. Some drugs rose slightly, and researchers say monitoring must continue.
